Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR-IPR-17013365Phase 4Not yet recruiting
Phase 4, open-label trial of omeprazole in obesity (2 arms), sponsored by Shanghai Sixth People's Hospital. Primary endpoint: Serum drug concentration of omeprazole. Planned start Dec 2017; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR-IPR-17013365.